Stephen H. Shoemaker has been appointed as a Director of 180 Life Sciences Corp (ATNF) effective December 3, 2024. This information was disclosed in a Form 3 filing with the United States Securities and Exchange Commission, indicating Shoemaker's initial statement of beneficial ownership of securities.The filing reveals that Shoemaker currently holds no beneficial ownership of any securities in the company, including both non-derivative and derivative securities. His address is listed as 3000 El Camino Real, Bldg. 4 Suite 200, Palo Alto, CA 94306.The Form 3 was signed by Shoemaker on December 10, 2024, a week after the event requiring the statement. As a director, Shoemaker will play a key role in the company's governance and strategic decision-making processes.

Stephen H. Shoemaker has been appointed as a Director of 180 Life Sciences Corp (ATNF) effective December 3, 2024. This information was disclosed in a Form 3 filing with the United States Securities and Exchange Commission, indicating Shoemaker's initial statement of beneficial ownership of securities.The filing reveals that Shoemaker currently holds no beneficial ownership of any securities in the company, including both non-derivative and derivative securities. His address is listed as 3000 El Camino Real, Bldg. 4 Suite 200, Palo Alto, CA 94306.The Form 3 was signed by Shoemaker on December 10, 2024, a week after the event requiring the statement. As a director, Shoemaker will play a key role in the company's governance and strategic decision-making processes.